Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Johnson & Johnson

NYS: JNJ

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Johnson & Johnson

Before the Bell

JNJ
/zigman2/quotes/201724570/composite

$

152.49

Change

+0.38 +0.25%

Volume

Volume 115

Nov 30, 2023, 4:56 a.m.

Real time quotes

/zigman2/quotes/201724570/composite

Previous close

$ 152.11

$ 152.11

Change

+0.48 +0.32%

Day low

Day high

$151.07

$152.20

Open
Open: 151.33

52 week low

52 week high

$144.95

$181.04

Open

Market cap

$365.02B

Average volume

6.44M

P/E ratio

29.03

Rev. per Employee

$624,414

EPS

5.24

Dividend

1.19

Div yield

3.13%

Ex dividend date

11/20/23

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/jnj

MarketWatch News on JNJ

  2. Finding Solid Dividends in Emerging Markets

    3:15 a.m. Nov. 23, 2023

    - Lawrence C. Strauss

  3. A Golden Age of Vaccines Is Here. What It Means for You.

    3:20 p.m. Nov. 21, 2023

    - Neal Templin

  5. Beneath October’s CPI Number: Inflation’s Untold Stories

    8:06 p.m. Nov. 17, 2023

    - Angela Palumbo

  6. Pharma's Out of Favor. 5 Drug Stocks That Can Grow.

    2:00 a.m. Nov. 16, 2023

    - Josh Nathan-Kazis

  8. Alcon’s stock falls as third-quarter sales miss estimates

    8:49 a.m. Nov. 15, 2023

    - Eleanor Laise

  11. Grab these 2 funds with rich 11%-12% yields while you can

    11:35 a.m. Nov. 11, 2023

    - Michael Brush

  15. Pharma Stocks Are Bleeding. 2 Look Like Bargains.

    10:51 a.m. Nov. 6, 2023

    - Josh Nathan-Kazis

  16. Drug Stocks Keep Tanking on Earnings. Brace for More.

    11:08 a.m. Oct. 30, 2023

    - Josh Nathan-Kazis

  17. Sanofi to Spin Out Consumer Health Division

    11:37 a.m. Oct. 27, 2023

    - Josh Nathan-Kazis

  19. 5 Consumer Staples Stocks to Buy Now

    1:04 p.m. Oct. 25, 2023

    - Lawrence C. Strauss

  20. The Bond Selloff Might Be Over. Buy These Stocks to Win.

    3:00 a.m. Oct. 25, 2023

    - Jacob Sonenshine

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/jnj

Other News on JNJ

  1. Barretts Minerals Fights to Keep Bankruptcy Case in Texas

    2:33 a.m. Nov. 29, 2023

    - The Wall Street Journal Interactive Edition

  2. The Stocks That AI Mania Left Behind

    2:32 a.m. Nov. 29, 2023

    - The Wall Street Journal Interactive Edition

  3. Bayer Stock Falls On Trial Halt, Roundup Verdict

    5:30 p.m. Nov. 21, 2023

    - The Wall Street Journal Interactive Edition

  4. Medical Studies Are Too White. Science Aims to Get Better Data.

    2:33 a.m. Nov. 20, 2023

    - The Wall Street Journal Interactive Edition

  5. Warren Buffett’s Berkshire Hathaway Sheds Investments in GM, J&J, P&G

    7:48 a.m. Nov. 15, 2023

    - The Wall Street Journal Interactive Edition

  6. Bayer Mulls Possible Split of Crops or Consumer Health

    5:34 a.m. Nov. 8, 2023

    - The Wall Street Journal Interactive Edition

  7. How Ozempic Maker’s Very Danish Capitalism Fueled Success—and Stumbles

    2:34 a.m. Nov. 8, 2023

    - The Wall Street Journal Interactive Edition

  8. Why Drug Companies Don’t Want to Sell Allergy Medicines and Bandages Anymore

    1:48 a.m. Oct. 30, 2023

    - The Wall Street Journal Interactive Edition

  9. This $5 Billion Biotech Home Run Took Less Than a Year

    1:33 a.m. Oct. 25, 2023

    - The Wall Street Journal Interactive Edition

  10. Johnson & Johnson Considers Ditching Texas Two-Step for Third Talc Bankruptcy

    1:33 a.m. Oct. 21, 2023

    - The Wall Street Journal Interactive Edition

  11. Bond Yields Hit Fresh Multiyear Highs After Hot Retail Sales Data

    1:34 a.m. Oct. 18, 2023

    - The Wall Street Journal Interactive Edition

  12. Johnson & Johnson’s Latest Talc Lawsuit Victory

    2:27 p.m. Oct. 15, 2023

    - The Wall Street Journal Interactive Edition

  13. CIOs Feel Heat From CEOs on Generative AI

    9:24 p.m. Oct. 2, 2023

    - The Wall Street Journal Interactive Edition

  14. Change Is Slow on Corporate Boards

    8:25 p.m. Oct. 2, 2023

    - The Wall Street Journal Interactive Edition

  15. This Cancer Therapy is Lifesaving, but There Isn’t Enough of It

    1:33 a.m. Sept. 22, 2023

    - The Wall Street Journal Interactive Edition

  16. Prison Health Contractor Expands Texas Two-Step Bankruptcy Tactic

    11:10 a.m. Sept. 19, 2023

    - The Wall Street Journal Interactive Edition

  17. J&J Revamps Drug Research, Plots Medical Device Deals

    1:32 a.m. Sept. 15, 2023

    - The Wall Street Journal Interactive Edition

  18. Big Pharma’s Battle With the Biden Administration Could Have Legs

    8:46 a.m. Sept. 13, 2023

    - The Wall Street Journal Interactive Edition

  19. J&J’s $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion 

    1:32 a.m. Sept. 8, 2023

    - The Wall Street Journal Interactive Edition

  20. Health Care Roundup: Market Talk

    6:15 a.m. Aug. 31, 2023

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...
/news/pressrelease/company/us/jnj

Press Releases on JNJ

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.